Assignee
ST PHI THERAPEUTICS CO LTD
CN·2 granted patents·3 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
5 records- 0160US2024425565A1Chimeric Natural Killer Cell Receptors and Method of Using ThereofST PHI THERAPEUTICS CO LTD·Filed 2024·Application pending·0 cites
- 0252US12312407B2Universal T cells and the method of use thereofST PHI THERAPEUTICS CO LTD·Filed 2021·Granted May 27, 2025·0 cites·20 claims
- 0344US2024335535A1Universal t cell and appication thereofST PHI THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0443US12018061B2Chimeric endocytic receptors and method of use thereofST PHI THERAPEUTICS CO LTD·Filed 2020·Granted Jun 25, 2024·0 cites·17 claims
- 0543US2025340599A1Targeted protein degradation system and use thereofST PHI THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ST PHI THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →